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Many studies of Respiratory Syncytial Virus (RSV) have relied on analyses of the
Major Surface Glycoprotein G gene (G gene). Global transmission patterns have not been
well studied due to lack of systematic global surveillance efforts. This study used
phylogenetic analysis of full genome data, categorized by geo-region, to determine the
sources of RSV A and B infection in Chile and Houston, Texas. Additionally, disease
severity studies have generally focused on outcomes associated with a single genotype. In
this study we developed a statistical phylogenetic approach to explore the relationship
between tree topology and disease severity. Disease severity data included if the patient was
given oxygen, if they were hospitalized, and if they were admitted to an intensive care unit.
Global data was downloaded from GenBank, separated into RSV A and RSV B,
aligned, and manually optimized. The United States and Canada region was overrepresented
in the publicly available data, so subsampling was conducted to reduce selection bias.
Starting trees were generated from the subsampled datasets using RAxML. Geographic traits
and trait state transition rates were jointly estimated in a Bayesian statistical framework using

BEAST. The global transmission network was estimated using the Bayesian stochastic search
variable selection and a constant population with a HKY genetic substitution model. Trait
associations were calculated using BaTS.
For RSV A, the time to most recent common ancestor (tMRCA) was 1963.40 (95%
BCI: 1946.15, 1969.60). For RSV B, the tMRCA was 1963.80 (95% BCI: 1959.50, 1967.33).
Europe and Central Asia was a key source of RSV A and B transmissions for both Chile and
Houston. In addition, the Middle East and North Africa and Latin America and the
Caribbean were sources of RSV transmission into Houston. For the RSV A clinical data,
there were significant associations between disease severity and tree topology when
analyzing all three traits together (AI 3.13 p<0.01, PS 22.39 p<0.01) and for oxygen (AI 0.98
p<0.01, PS 9.32 p<0.01) and hospitalization independently (AI 1.92 p<0.01, PS 11.78
p<0.01). No significant association was found between tree topology and ICU admission. No
significant associations were found in the RSV B clinical data, which may be due to the
small sample size and homogeneous outcomes in this group.
Improved surveillance systems are needed to gain a better understanding of global
transmission patterns to complement studies done of local transmission patterns, as global
introductions play an important role in local outbreaks. Identifying genetic mutations that
lead to more severe outcomes may help researchers target vaccine development.
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BACKGROUND
Literature Review
Respiratory Syncytial Virus (RSV) was first isolated in 1956 in Chimpanzees by Dr.
J.A. Morris and colleagues (Orga, 2004). It was isolated from humans for the first time later
that year from two infants, one with pneumonia and one with croup (Chanock, et al., 1962).
One of the first RSV epidemiological studies in 1962 noted that “RS virus appears to become
disseminated extensively in the pediatric population every year (Chanock, et al., 1962).”
Today we have more information on the epidemiology of the disease and its ubiquitous
nature; it is estimated that almost every child has been infected by the age of two (Bont, et
al., 2016). In the era of genetic sequencing, efforts to study transmission and severity through
phylogenetics originally focused on partial sequencing of the G gene, which codes for the
attachment glycoprotein (Schobel, et al., 2016), but the focus has recently shifted to
collecting and using full genome data in analyses to better understand transmission dynamics
not readily apparent in traditional epidemiologic and G gene data.
RSV Genome and Genotypes
RSV is an enveloped, negative-sense, single-stranded RNA virus, with a nonsegmented genome that is about 15,000 nucleotides long (Borchers, et al., 2013). Along with
the mumps virus and parainfluenza, RSV is a member of the Paramyxoviridae family and of
the genus Pneumovirus. The virus has two major antigenic types, A and B, which are
classified by differences in reaction to monoclonal antibodies, although there is significant
genetic variability within each group (Duvvuri, et al., 2015; Orga, 2004).
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The RSV genome has 10 genes that code for 11 proteins (Schobel, et al., 2016).
Genes G, F, and SH code respectively for attachment glycoprotein, fusion glycoprotein, and
small hydrophobic protein, which play roles in viral attachment and entry to host cells
(McLellan, Ray, & Peeples, 2013; Tan, et al., 2013). The remaining genes code for
nonstructural proteins (NS1 and NS2), nucleocapsid protein (N), phosphoprotein (P), matrix
protein (M), transcription regulators (M2-1 and M2-2), and large polymerase (L) (Schobel, et
al., 2016; Tan, et al., 2013).
The G gene produces the key surface glycoprotein in viral binding to host cells and is
often called the attachment protein (McLellan, Ray, & Peeples, 2013). This gene has
traditionally been the focus of studies on the evolutionary history of RSV because there is a
hypervariable region at the C-terminus that contains most of the genetic variation in the
genome (Schobel, et al., 2016). Before whole genome sequencing for RSV was widespread,
it was easier to base analyses on this section of the gene since it was thought to be the
location demonstrating most evolutionary signals (Schobel, et al., 2016). It has also been
suggested that the lack of cross-immunity between types and genotypes is due to variation in
the G gene (Tan, et al., 2013). Genotypes of RSV are currently classified by this
hypervariable region in the G gene (Hibino, et al., 2018). There has been disagreement on the
classification and naming of RSV genotypes, but there are two that are easily identified due
to insertions in the G gene: RSV A genotype ON1 and RSV B genotype BA. RSV A
genotype ON1 has a 72-nucleotide duplication that is not present in other common A
genotypes, such as NA1 and GA2 (Schobel, et al., 2016). RSV B genotype BA has a similar
duplication in the same region that is 60-nucleotides long, this duplication is also missing in
2

other genotypes of B (Schobel, et al., 2016). ON1 and BA have been the dominant genotypes
in recent outbreaks (Cui, et al., 2013; Tabatabai, et al., 2014).
The F gene, which is sometimes analyzed in conjunction with the G gene, codes for
another surface glycoprotein that is key to viral entry to host cells (Schobel, et al., 2016).
This protein has a pre-fusion form and a post-fusion form, and critical antigenic sites in the
protein have been used in vaccine design (Hause, et al., 2017). Compared to G gene, the F
gene is well-conserved across all genotypes of both RSV A and B (McLellan, Ray, and
Peeples, 2013). A study conducted by Hause and colleagues found more genetic variability
than previously thought, especially in the pre-fusion antigenic sites, and more variations in
RSV B sequences than RSV A sequences (2017). Another gene that plays a role in viral entry
and is often not included in epidemiologic analyses is the SH gene. SH codes for the small
hydrophobic protein that changes the permeability of the host membrane and aids in viral
entry to host cells, although it is not necessary for entry (Tan, et al., 2013).
Epidemiology
In temperate climates, RSV circulation shows seasonal patterns similar to seasonal
influenza, with peaks in the winter months and fewer infections in the summer. In the
Northern Hemisphere, the season normally starts in October or November and ends in March
or April, with an epidemic peak occurring between December and February (Bont, et al.,
2016). Like influenza, RSV can spread through aerosolized droplets generated by coughs or
sneezes, and the virus is able to live on hard surfaces for several hours (CDC, 2017).
According to the US Centers for Disease Control and Prevention (CDC), children are most
often exposed to the virus at school or day-care and then cause household transmission
3

(CDC, 2017). Historical data are largely focused on the United States, although more recent
studies on the epidemiology of RSV have been conducted in a large number of countries
around the world. Increasing the number of countries and regions represented in the publicly
available dataset makes it possible to study the larger patterns of disease transmission.
RSV infections usually cause mild, cold-like signs and symptoms, but high-risk
populations can develop more severe complications, including bronchiolitis, pneumonia,
and/or death. RSV “has a propensity for causing bronchiolitis,” and often produces a form of
the disease that is longer in duration and more severe than bronchiolitis from other causes
(Pickles & DeVincenzo, 2017). High-risk populations listed by the CDC include infants
under 6 months of age, infants born prematurely, especially if the infant has chronic lung or
heart disease, children with reduced immune function, and adults over the age of 65,
especially those with weakened immune system or chronic heart or lung disease (CDC,
2017). Although the risk of severe complication requiring hospitalization is higher in infants
with chronic diseases and premature birth at the individual level, the majority of admissions
occur in children who are not high-risk (Bont, et al., 2016). Over 70% of pediatric hospital
admissions for RSV have no underlying medical conditions, so although their individual risk
is lower, previously healthy children make up the majority of cases (Bont, et al., 2016).
A meta-analysis of all available epidemiologic studies on RSV to determine its global
impacts, conducted by Shi and colleagues, found that 22% of all severe cases of acute lower
respiratory infections were due to RSV in children under the age of 5, resulting in around 3.2
million hospitalizations and 59,600 deaths in hospitals (2017). Almost half of the
hospitalizations and deaths, 1.4 million and 27,300 respectively, occurred in children under
4

six months of age (Shi, et al., 2017). The original Global Burden of Disease Study estimated
that 6.7% of all deaths in children 1 month to 1 year old were due to RSV, as were 1.6% of
all deaths in children ages 1 to 4 (Lozano, et al., 2012). The rate of hospitalization and case
fatality rates within hospitals varied by the country’s income level as defined by the World
Bank. Lower hospitalization rates were found in low income countries and rates increased as
the economic situation of the country improved (Shi, et al., 2017). Two reasons for this
discrepancy is poor access to care in resource constrained locations, and poor care-seeking
behavior, although Shi and colleagues do not state whether this is due to a family’s inability
to pay or mistrust of the medical system (2017). Case fatality rates trended in the opposite
direction; death rates were higher in low income countries and the rates decreased as income
status increased (Shi, et al., 2017).
To date, the Shi study has been one of the most comprehensive reviews of the burden
of RSV globally, although it is likely that the true burden of the disease has been
underestimated because the study only counted cases that were admitted to the hospital. In
places where access to medical care is limited, patients may not be able to go the hospital and
those cases would go unreported and unaccounted for in this burden analysis. The
underestimation is compounded by gaps in the data, as there are many areas of the world
where data on RSV have not been collected (Shi, et al., 2017). To address this problem, the
World Health Organization launched the Global RSV Surveillance pilot, which “aims to test
the feasibility of leveraging the Global Influenza Surveillance and Response System platform
for RSV surveillance without adversely affecting the well-established surveillance of
influenza (WHO, 2017).” More data on the distribution of RSV and its molecular
5

epidemiology will aid efforts to better understand the transmission patterns and determinants
of disease in order to better control its spread, and eventually to design effective RSV
vaccines (WHO, 2017).
Molecular Epidemiology and Global Transmission
Many studies have focused on local circulation patterns of RSV genotypes across
seasons or within a single season using local surveillance data (Hibino, et al., 2018; de-Paris,
et al., 2014; Esposito, et al., 2015; Tran, et al., 2013; Panayiotou, et al., 2014). The dominant
type can alternate between A and B across seasons, and the dominant genotypes can also
change across seasons. For example, RSV A genotype NA1 was the dominant type in Japan
before the introduction of ON1, which then became the dominant genotype (Hibino, et al.,
2018). Multiple genotypes from both RSV A and B types can circulate concurrently within a
single season, increasing the complexity of circulation patterns. (Schobel, et al., 2016). Many
studies conducted on the distribution of RSV focus on identifying the dominant and cocirculating genotypes in one location and provide limited analysis of the geographic
transmission (Hibino, et al., 2018; de-Paris, et al., 2014; Esposito, et al., 2015; Tran, et al.,
2013). Very few studies connect this local data to publicly available global data to place local
outbreaks in the context of the larger phylogenic tree, which would allow investigators to
make inferences about the source of the disease in their country or locality and about global
transmission patterns.
Global transmission patterns have not been well studied due to lack of systematic
global surveillance efforts and the resulting large gaps in the information available to
investigators (Duvvuri, et al., 2015; Zou, et al., 2016). One of the few studies to take the
6

global view, focused only on the distribution of the ON1 genotypes, as defined by the G gene
(Duvvuri, et al., 2015). They estimated that ON1 emerged in 2007 or 2008 in Ontario,
Canada, and by the time the study was conducted it had been detected on every continent
(Duvvuri, et al., 2015). The phylogenic tree produced in the study did not appear to show a
strong association between clade and geography, although this could be due to the limited
amount of data available (Duvvuri, et al., 2015). Duvvuri and colleagues suggested that
irregular clusters, such as one including Canada, United States, Thailand, and Italy, could be
due to patterns in travel (2015). One limitation of this study is that they used data only on the
second hypervariable region of the G gene, instead of using a whole genome approach to
infer global patterns (Duvvuri, et al., 2015).
Another study analyzing sequences from Guangdong, China, in conjunction with
sequences from publicly available strains indicated the dominant strains GA2 and ON1
originated in the Americas before spreading to other regions (Zou, et al., 2016). The
investigators noted that this result could be due to bias in the dataset, since most early
samples are from the United States and much of the available data is also from this country
(Zou, et al., 2016). In the phylogenetic tree generated by the study, they found that many
clades contained viral strains from multiple geographic areas, but several clades represented
only Guangdong (Zou, et al., 2016). This indicates that there were introductions of RSV from
other regions, but seasonal epidemics may also have been seeded by locally persistent strains
of the virus (Zou, et al., 2016). However, analyses are biased towards identifying local
persistence because of a lack of information from other regions (Zou, et al., 2016).
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The Zou study had two main limitations: their analysis relied on just G gene
sequences, similar to many other molecular epidemiologic studies; and their geographic
analyses relied on four large regions, which limits the utility of the findings (Zou, et al.,
2016). Reliance on the G gene does not present the whole evolutionary history of the virus,
but RSV whole genome analyses are rare. One study conducted by Bose and colleagues
found a similar pattern to Zou (2016). Their analysis found several genotypes were
circulating simultaneous across the globe, but that some rarer genotypes were only found
within one area; which is probably due to inconsistent surveillance around the world as these
rare genotypes were found in areas with more data (Bose, et al., 2015). Unlike the Zou study,
Bose and colleagues did not note a strong relationship between geographic location and
clades on the phylogenic tree, which indicates that RSV is not evolving independently and
separately in one locale and there is interaction between regions (Bose, et al., 2015).
As more whole genome data has become available and more advanced
phylogeographic methods are developed, global transmission patterns of RSV can be better
explored. Understanding both local and global dynamics using a phylogeographic approach
will reveal the relative importance of international introductions in these seasonal epidemics
and inform surveillance programs and control measures in the future.
Patterns in Severity of Disease
Although much attention has been paid to the severity of RSV infection in relation to
host factors, such as immunosuppression or chronic health conditions, many studies indicate
that severity is related to more than just host factors. Some viral genome characteristics can
also be important determinants of viral pathogenicity, resulting in different levels of disease
8

severity. However, viral genetic characteristics and RSV pathogenicity have not been well
connected. Most studies focus on the relationship between disease severity and RSV
genotype with inconsistent results. One such study conducted over three epidemic seasons in
Japan found that 35.6% of those infected with ON1 were hospitalized, indicating more severe
disease, and this proportion was greater than all other measured genotype hospitalization
rates (Hibino, et al., 2018). The odds ratio of hospitalization for those infected with ON1 to
those infected with NA1 was 6.92:1, and there was no significant difference in the odds of
hospitalization between NA1, BA9, and BA10 infections (Hibino, et al., 2018). Yoshihara
and colleagues found similar results in Vietnam, where the risk of lower respiratory tract
infections was 2.26 times higher in those with ON1 compared to those with NA1 (2016).
This is opposed by results from a study in Northern Italy, in which NA1 was more likely to
cause upper respiratory tract infections and require hospitalizations than ON1 (Esposito, et
al., 2015). In a population where ON1 was not detected, Luchsinger and colleagues found
that infection with NA1 was more likely to cause hospitalization and severe disease than two
RSV B genotypes (2014). In Cyprus, researchers found that RSV A genotype GA2 and RSV
B genotype BA both caused more severe disease than ON1 (Panayiotou, et al., 2014). They
also found that a larger proportion of those infected with BA required oxygen, suggesting BA
causes severe outcomes more frequently than other genotypes, in contrast to common results
indicating that RSV A is more likely to cause severe disease (Panayiotou, et al., 2014).
Espinosa and colleagues also looked for a relationship between genotype and disease severity
in Chile but did not find any significant interaction between viral type or genotype and
disease severity (2017).
9

Since multiple studies have yielded mixed results, the links between genetic
characteristics of RSV and disease severity are equivocal. Many studies have focused on
relating genotype to severity, but these studies have been inconclusive due to limited sample
size and the large variations within genotypes. The reliance on just the G gene in genotyping
may also play a role in the muddled findings, since other genes inducing host immune
responses are ignored. These other genes, especially the F gene, may have important genetic
differences that lead to differences in disease severity, but these characteristics have not yet
been identified because a genomic approach has rarely been applied in these analyses.
A few studies on differences of disease severity among RSV strains have been
conducted in vitro, which reported different levels of cytokine activation across strains, but
not across genotypes. Levitz and colleagues (2012) studied the effects of different strains
collected from patients to produce varying inflammatory cytokine (IL-6) responses. An
increase in IL-6 production is part of the body’s immune response to RSV infection. Their
analysis focused on RSV A, genotypes GA2, GA3, GA4, and RSV B and found that the level
of IL-6, an inflammatory cytokine, varied greatly across strains within the same genotype,
between RSVA and B, and by genotypes at the same level (Levitz, et al., 2012). A similar
study by Thompson and colleagues (2015) observed disease severity in patients and
compared severity with in vitro cytokine induction for four cytokines (IL-1α, IL-6, IL-8 and
RANTES). There was no significant difference between strains in IL-6 levels, which differs
from the results of the Levitz study, but instead there were significant differences between
strains in the production of two other inflammatory cytokines, IL-8 and RANTES (Levitz,
2012; Thompson, et al., 2015). There were no significant trends in activation of cytokines
10

across RSV types and genotypes, in contrast to many studies on disease severity which focus
on genotyping discussed above (Thompson, et al., 2015; Hibino, et al., 2018; Esposito, et al.,
2015; Panayiotou, et al., 2014). These data support the use of full genome data when
investigating the connection between disease severity and the strain of RSV, since few trends
were seen across genotypes, which indicates that the genetic predictor of disease severity
could be located in another part of the genome.
Knowledge Gaps
In summary, we have identified two major gaps in the literature on RSV transmission
and disease severity: 1) RSV whole genome data has not been used for inferring global
transmission patterns, and current studies rely solely on the G gene, so incomplete lineage
sorting could be a confounding variable in relationships proposed by most of these studies; 2)
RSV disease severity has been mostly studied at the genotype level, but strain-specific
genetic characteristics have not been explored. These two gaps are critical to understanding
the epidemiology and burden of RSV. A better understanding of RSV transmission patterns
will help inform prevention strategies, and genetic characteristics related to disease severity
could provide valuable information for antiviral drug and vaccine design.

Public Health Significance
RSV is important to public health because of its ubiquitous nature and the potential
for severe complications in high-risk populations, including children under the age of 5 and
adults over the age of 65. Assessments of the impact of RSV have focused on young
children, so the burden of disease in the elderly often has been overlooked. It is estimated
11

that close to 60,000 hospitalizations each year in the United States could be attributed to RSV
in children 5 years old and younger, and half a million emergency room visits every year
(Breese Hall, et al., 2009). The number of hospitalizations of those over the age of 64 was
estimated to be 180,000 per year in the United States, close to three times the number in
children (Falsey, et al., 2005). A review of insurance claims data showed that the expense of
hospital stays related to RSV was significantly higher than the cost for non-RSV controls
across all age categories except for patients ages 5 to 17 (Amand, et al., 2018). The highest
discrepancy in cost occurred in those ages 75 to 84, where an average of $17,211 was spent
on non-RSV controls and an average of $40,405 was spent on RSV cases (Amand, et al.,
2018). These estimates do not include outpatient costs or lost productivity, so there is a large
economic impact in addition to the burden on healthcare utilization (Amand, et al., 2018;
Falsey, et al., 2005).
It is estimated that almost everyone has been infected by the age of two, but this
history of infection does not induce lifelong immunity (Brochers, et al., 2013). Since no
vaccine currently exists, although there are several in various clinical stages of development,
it is especially important to understand global and local transmission dynamics to inform
infection control measures. In this study, we propose to explore the RSV strains from Chile
and Houston, Texas, in the context of global transmission patterns inferred from publicly
available full genome data to identify potential sources of infection during seasonal
outbreaks. Chile and Houston were selected due to collaboration agreements between
investigators at Baylor College of Medicine, University of Chile College of Medicine, and
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Dr. Bahl at the University of Texas Health Sciences Center. These data will facilitate further
exploration of transmission paths between geo-regions and inform prevention strategies.
Viral genetic information paired with patient outcome information can elucidate the
relation between the genetic characteristics of RSV and disease severity to target vaccine
development on strains with the highest contributions to the burden of disease. Although
host factors, viral dose, and region of the lung infected all play important roles in the severity
of disease, it is equally important to understand strain specific responses and severity since
previous in vitro and epidemiological studies have investigated the link between RSV
genotype and disease severity. The strains collected from Chile and Houston include
information on patient outcomes (if the patient needed oxygen and admission to a hospital or
intensive care unit), so clusters or specific genetic characteristics that are associated with
high disease severity can be identified.

Specific Aims
Previously, much attention has been paid to local patterns of RSV infection and
disease severity by genotype because local transmission was not well understood. Many of
these studies indicate that dominant genotypes that were not previously present in their area
were introduced from an outside source. As the understanding of local dynamics has
improved and the amount of global data have increased, it has become possible to investigate
transmission dynamics on a larger scale. Studies on these global patterns indicate that there is
a mixture of local persistence and global introduction of RSV based on the G gene only, but
no studies so far have tried to apply a source-sink model with RSV full genome data to infer
13

the global transmission pattern. Studies of disease severity have also focused on identifying
the genotypes that caused the largest number of most severe cases, which has led to
inconsistent conclusions due to the diversity within each genotype, and no studies have been
conducted to investigate the relationships between strain-specific genetic characteristics and
disease severity via the phylogenetic approach. With publicly available full-genome data
from around the world, the samples from Chile and Houston, Texas, and detailed data of
disease severity, we want to answer the questions: 1) What is the RSV global transmission
pattern? 2) What are the sources of RSV samples collected in Chile and Houston, Texas
between 1987 and 2014? 3) Are certain viral genetic characteristics associated with
hospitalization and ICU admission in Chile and Houston? This information can help inform
surveillance strategies, similar to what has been done with influenza, and help target vaccine
development to protect against genetic characteristics associated with more severe outcomes.
Specific Aims:
1. To understand where the isolates from Chile and Houston are located in the global
tree and identify global transmission patterns using phylodynamic source-sink
modeling.
2. To explore the correlation between viral genetic characteristics and severe
outcomes with clustering analyses.

14

METHODS
Study Population & Data Set Compilation
All publicly available RSV sequences with over 5,000 nucleotides were downloaded
from GenBank (https://www.ncbi.nlm.nih.gov/genbank/). The accession numbers for each
sequence were downloaded manually. Geographic and collection date information was
abstracted from the textual and tabular contents of full-text publications by employing
GeoBoost, which is a Java program to extract and normalize the location of infected host of
viruses from the metadata files and related published records (Tahsin, et al., 2017). The
associated metadata, including the date of collection and geographic data was matched with
sequence data from GenBank via its unique accession number.
The G, F, and SH gene data with detailed information on disease severity from Chile
and Houston was shared by the collaborating investigators in Houston and Chile. Data from
Houston were collected from children with lower respiratory infections between 1987 and
2005. These samples have been used previously to study the genetic variability of the G, F,
and SH genes (Tapia, et al., 2014). The data from Santiago de Chile were collected as part of
a study investigating the effect of sequence variation of the G, F, and SH genes on immune
response and disease severity (Tapia, et al., 2012). Older sequences from Chile are from 1990
to 2010 and were sampled from the biorepository at the University of Chile. Strains from
2010 to 2014 were taken from a cohort of RSV infected infants at Hospital Roberto del Rio
during these outbreaks. Tapia and colleagues also conducted a chart review to abstract
information on the patient’s age, sex, and disease severity. Disease severity was evaluated

15

with three dichotomous variables: given oxygen therapy, hospitalization, and admission to
the intensive care unit (ICU).
The full dataset from publicly available data and from collaborators was then
separated into RSV A and RSV B for alignment and manual optimization. The data were
aligned using MUSCLE v3.8.31 (Edgar, 2004). The aligned data were reviewed and cleaned
using BioEdit (Hall, 2005). Manual optimization of the alignment was then conducted to
correct artificial gaps inserted into the data by strains with non-base insertions (N instead of
A, T, C, or G). Strains without geographic information or the year of collection were
removed. If no day information was available then the strain was assigned to the 15th of that
month; if day and month information was missing then the strain was assigned to the first of
July of that year. Duplicate strains were removed in RAxML and the oldest strain was
retained (Stamatakis, 2014). TempEst (http://tree.bio.ed.ac.uk/software/tempest/) was used to
identify outliers and investigate the temporal structure or signals of molecular clock in the
dataset (Rambaut, et al., 2016).
After outliers were removed from the dataset, the temporal and geographic
distributions of RSV A and RSV B were analyzed in Tableau (https://www.tableau.com/) and
it was determined that subsampling was necessary. Across several years, some countries
were overrepresented in the data, which were then selected for subsampling. We defined
overrepresentation as having more than 25 strains for RSV A and more than 20 strains for
RSV B from one country in any given year. The selection of strains to be included in the
subsample was conducted by randomly selecting accession numbers from the
overrepresented groups to get the sample sizes above. Two subsampled datasets were
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generated for both RSV A and B for the purpose of sensitivity analysis and quality control.
Strains that were not selected were excluded from further analysis to reduce sampling bias in
the dataset.
Maximum Likelihood Phylogenetic Analysis
A maximum likelihood (ML) tree to preliminarily explore the phylogeny in the full
dataset was generated in RAxML using the General Time Reversible (GTR) nucleotide
substitution model with GAMMA distribution of rate heterogeneity among sites. The two
subsampled datasets were also run through RAxML using the same substitution model. The
resulting ML trees estimated the time to most recent common ancestor (tMRCAs) and the
substitution rates were compared to each other and to the full dataset, in order to check the
quality of the subsampling strategy. To evaluate the reliability of tree topologies,
bootstrapping analyses were conducted with the extended majority rule consensus tree
criterion (that is, autoMRE option in RAxML) which automatically determines the sufficient
bootstrap replicates for getting stable support values. Trees rooted with mid-point root were
visualized and colored in FigTree v1.4.2 (http://tree.bio.ed.ac.uk/software/figtree/).
Bootstrapping values were shown on the tree nodes.
Bayesian Phylogenetic Analysis
The phylogeny of the subsampled datasets was reconstructed using Bayesian Markov
chain Monte Carlo (MCMC) methods in the Bayesian Evolutionary Analysis by Sampling
Trees (BEAST) v1.8.4 with the ML trees as starting trees (Drummond, et al., 2012). The tree
topology, the evolutionary rates and tMRCAs were co-estimated. HKY nucleotide
substitution model with GAMMA distribution of rate heterogeneity among sites was used to
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depict the pattern of nucleotide changes (Hasegawa, Kishino, & Yano, 1985). The
uncorrelated log-normal relaxed clock model was used to calibrate time information on tree
branches (Drummond, et al., 2006). Due to computing constraints, a constant coalescent prior
was used for the global datasets (Drummond, et al., 2002). To generate a set of empirical
trees, two independent MCMC analyses with chain length of 150 million were run until
reaching good convergence, with sampling every 15,000th generation and resulting in 10,000
states or trees output in log and tree files, respectively. The empirical trees for RSV A and
RSV B were then used for the global transmission analysis. Tracer v1.7 was then used to
visualize and assess how well these runs have converged; the convergence of combined
chains from two runs was determined to be acceptable when the estimated effective sample
size (ESS) > 200 after removing the burn-in (Rambaut, et al., 2018). With well-converged
runs, log and tree files from these runs were combined in BEAST LogCombiner. Then
BEAST TreeAnnotator was used to annotate one maximum clade credibility (MCC) tree
from the combined tree file. Uncertainty from Bayesian analysis was indicated by 95%
highest posterior density (95% HPD) also called the 95% Bayesian Credible Interval. The
estimated tMRCA and evolutionary rate were reported with mean value and 95% HPD,
respectively.
Discrete phylogeographical analysis
To make inferences about global transmission dynamics and to guarantee sufficient
samples in each geographic discrete trait, collection location (country) of each sequence was
coded into six regions defined by the World Bank: East Asia and Pacific (EAP), Europe and
Central Asia (ECA), Latin America and Caribbean (LAC), Middle East and North Africa
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(MEN), South Asia (SA), Sub-Saharan Africa (AF) (World Bank Group, 2018). High income
countries, which are not categorized by the World Bank, were added to the nearest region. In
the results, Western Europe was categorized as a part of ECA, and Australia was in EAP.
The United States and Canada (UC) region was created as an additional region. Houston and
Chile were categorized as additional regions to assess transmission into and out of these
locations, resulting in a total of nine regions as the discrete geographic traits. With the same
substitution model, molecular clock and coalescent models from the previous section
(“Bayesian Phylogenetic Analyses”), the Bayesian stochastic search variable selection
(BSSVS) approach was applied to the sets of empirical trees generated above to find a
parsimonious set of rates explaining the geographic diffusions in the phylogeny. Three runs
with a chain length of 100 million were conducted. The process for checking convergence
and combining the runs was similar to the procedure outlined above.
The BSSVS approach enabled us to construct a Bayes factor (BF) test to identify
significant diffusion processes between discrete geographic traits (Lemey, et al., 2009). The
criteria for significance of the BFs were in accordance with Kass and Raffery’s definition:
BF≥3 is considered significant (1995). We further categorized the level of support into five
groups: 3≤BF<6 as weak supported, 6≤BF<10 as substantial support, 10≤BF<30 as strong
support, 30≤BF<100 as very strong support, and BF≥100 as decisive support (Bahl, et al.,
2013). Transmission pattern and BF results were visualized using SpreaD3 (Bielejec, et al.,
2016).
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Furthermore, to quantify how many times the transmissions occurred between georegions, Markov jump counts for each node of the ancestral reconstruction were assessed
based on the global tree (Minin & Suchard, 2008). A non-reversible model was used to
determine the directionality of the transmission, so that an asymmetric matrix was
constructed to assess source-sink dynamics among the sampled geo-regions. Heat maps to
represent the estimated jump counts between two locations were used to show the
connections of geo-regions.
Bayesian Tip-Association Significance Testing Analysis
To explore the correlation between viral genetic characteristics and disease severity,
the subset of data from Houston and Chile during 2010-2014 with disease severity
information was used to conduct clustering analysis. G, F and SH genes were linked and
analyzed as one set in the BEAST phylogenetic analysis. The uncorrelated log-normal
relaxed clock model and HKY nucleotide substitution model with GAMMA distribution
were used for the analysis of the local data (Hasegawa, Kishino, & Yano, 1985; Drummond,
et al, 2006). For the local data, the GMRF Bayesian Skyride with time-aware smoothing
process was used as the coalescent prior to accommodate changes in the effective population
size (Minim, Bloomquist, & Suchard, 2008; Drummond, et al., 2002). The chain length was
set to 100 million with sampling every 10,000th generation, and three runs were conducted.
LogCombiner and BEAST TreeAnnotator were used to combine the log files and create one
MCC tree.
The MCC tree generated in BEAST for the data from Chile and Houston was
analyzed further in Bayesian Tip-association Significance testing (BaTS) to determine if
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there is a relationship between disease severity and tree topology (Parker, Rambaut, & Pybus,
2008). Disease severity traits, analyzed as dichotomous variables, included if oxygen therapy
was needed, if they were admitted to the hospital, and if they had to be admitted to an
intensive care unit (ICU). These traits were analyzed together, and also separately to identify
the association between single disease severity trait and genetic characteristics. A single
configuration was run in the BaTS program, where an Association Index (AI), Finch’s
parsimony score (PS), and a monophyletic clade (MC) size statistic were calculated to
determine the strength of association. The AI tests for the consistency of a trait across
internal nodes of the tree, and a lower number represents a stronger relationship between tree
topology and the trait of interest. The PS takes into account the number of trait changes
beyond each ancestral node, where the score is reported as an integer and lower numbers
indicate a stronger relationship between the trait and tree structure. The MC statistic assumes
that if a clade is monophyletic for the trait of interest, then the MC value is high and the
relationship between tree topology is strong. Clusters that are significantly correlated with
high disease severity were reported with the corresponding p-value.
Ethics Statement
All data used in this study were de-identified before we received the datasets from
Chile and Houston. No further medical or demographic information was collected from these
patients, and we did not have access to their medical records. The original data collection in
Chile and Houston was carried out with IRB approval. Publicly available data from GenBank
does not include protected health information or personal identifiers of patients from which
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the samples were isolated. The protocol for this secondary data analysis was submitted for
IRB approval within the University of Texas Health system and determined to be exempt.

RESULTS
Global Transmission Dynamics
Global Distribution of RSV Samples
Originally, 1,186 RSV A sequences were downloaded from GenBank and 143
samples came from collaborators in Chile and Houston. For RSV B, 486 sequences were
downloaded from GenBank and 107 came from study collaborators. After removing
duplicates, lab strains, and outliers, there were 1,123 RSV A sequences and 568 RSV B
sequences (see Figures A1a and A1b for global distribution of these samples). After
subsampling, there were 739 RSV A sequences and 474 RSV B sequences included in the
analyses. Of 739 RSV A sequences, 54 were from Chile and 67 were from Houston. Of the
474 RSV B sequences, 44 taxa were from Chile and 37 were from Houston. By geo-region,
the vast majority of RSV A sequences were from the UC region (n=284), as were the
majority of RSV B sequences (n=178). EAP (n=115) was the second most common region in
the RSV A dataset, and ECA (n=74) was the second most common region among the RSV B
samples. SA was the least common region; only two RSV A sequences came from SA, and
no RSV B sequences came from this region (see Figures 1a and 1b for the distribution of
sequences by geo-region).
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Figure 1. Distribution of Subsampled Sequences by Geo-Region

The number of RSV A (a) and B (b) sequences from each of the adapted World Bank regions included in the
subsampled dataset for further analyses.

Bayesian Phylogenetic Analysis
The MCC trees for RSV A and B were generated and coded by geo-region to make
inferences about global transmission dynamics. The MCC tree for RSV A (Figure 2) has two
large clusters that have been co-evolving and co-circulating. One cluster is largely made up
of sequences from the UC region, with some small clusters from Houston, ECA, and LAC.
The other large cluster was less dominated by the UC region and contained clusters from
EAP, LAC, and AF. There were also smaller clusters from the MEN, Houston, and Chile.
The tree shows two major lineages with bushy leaves in the more recent time period, which
indicates intense sampling efforts in more recent times. Multiple lineages co-circulate over
time suggesting a higher standing genetic diversity than observed in other RNA viruses
causing respiratory disease, such as Influenza A virus. The longer branches on the older part
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of the tree indicate that there was missing information, probably due to a lack of RSV
surveillance, which increases the uncertainty of the tMRCA estimation. The RSV A tMRCA
for the sample of publicly available data and the clinical data from Chile and Houston was
estimated to be 1963.40 (95% BCI: 1946.15, 1969.60), with a mean substitution rate of
7.43x10-4 substitutions/site/year. This is a relatively wide Bayesian credible interval,
indicating the uncertainty of the estimation is increased by missing data at early stages of
RSV surveillance.
Figure 2. Bayesian Maximum Clade Credibility Tree for Global RSV A

The MCC tree for RSV A color coded by geo- region. High income countries were added to the closest region,
and the United States and Canada was added as another region.
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The RSV B MCC tree (Figure 3) has a pronounced ladder shaped phylogeny with
bushy leaves. Similar to the RSV A tree, there has been intensive surveillance in more recent
times. In contrast, all co-circulating RSV B lineages have a more recent common ancestor
from 2000.90 (95% BCI: 2000.88, 2001.93). The RSV B tree also has some long branches,
which indicates that data is missing from the globally available dataset. The older clusters are
mostly from the UC. The more recent clusters are mainly composed of strains from ECA,
with smaller clusters from Chile, AF, EAP, and the UC. The RSV B tMRCA was 1963.80
(95% BCI: 1959.50, 1967.33) with a mean substitution rate of 8.34x10-4
substitutions/site/year. The Bayesian credible interval is relatively smaller, so this estimate
has less uncertainty.
Figure 3. Bayesian Maximum Clade Credibility Tree for Global RSV B
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The MCC tree for RSV B color coded by geo-region. High income countries were added to the closest region,
and the United States and Canada was added as another region.

RSV Global Transmission Patterns
The transmission rates and Bayes factors were generated to identify potentially
important transmission routes on the global level. The key transmission routes for RSV A
(Figure 4 and Table B1) were from ECA to LAC, EAP, AF, and EAP to MEN. These routes
had the highest transmission rates (2.666, 2.086, 1.343, and 1.678 transitions per year,
respectively) and had decisive statistical support (BF>100). ECA to the UC also had one of
the highest transmission rates (2.523) but was not supported (BF<3).
Figure 4. Map of Global Transmission Rates for RSV A

Map of global transmission patterns for RSV A. Only transmissions with BF≥3 are shown. The color of the line
indicates the level of support, and the weight of the line indicates the rate of transmission with thicker lines
indicating a higher rate. Arrowheads indicate the direction of transmission. UC is the United States and Canada
region, LAC is Latin America and the Caribbean, ECA is Europe and Central Asia, MEN is the Middle East and
North Africa, AF is Sub-Saharan Africa, SA is South Asia, and EAP is East Asia and the Pacific.

Transmission from LAC into Houston was weakly supported (3≤BF<6) and the rate
was low (0.584 transitions per year). There was substantial support (6≤BF<10) for Houston
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as a sink for EAP at a rate of 0.515 transitions per year. MEN and AF were strongly
supported (10≤BF<30) sources of virus for Houston (0.841 and 0.425 transitions per year,
respectively). Transmission routes from SA and ECA to Houston had decisive support
(BF≥100), although the rate from SA (0.289 transitions per year) was much lower than the
one from ECA (1.438 transitions per year). Houston was a very strongly supported
(30≤BF<100) source of infection to MEN (0.787 transitions per year).
Transmission from Chile to SA and from Chile to EAP is weakly supported
(3≤BF<6), and rates for these transmissions were low (0.192 and 0.767 transitions per year,
respectively). ECA was a substantially supported source of infection for Chile, at a rate of
0.666 transitions per year, and EAP into Chile was strongly supported at a rate of 0.711
transitions per year. There was decisive support for SA and LAC as sources of infection for
Chile. The rate of transmission from LAC into Chile was 1.500 transitions per year, the
highest rate of all transmissions involving Chile, and the rate from SA was very low (0.269
transitions per year). Chile was a very strongly supported source of infection for ECA, with a
rate of 1.476 transitions per year.
In RSV B (Figure 5 and table B2), transmission routes from ECA to UC and to EAP
had the highest rates (2.854 and 2.815 transitions per year, respectively), and these routes had
decisive support (BF>100). Routes from ECA to AF, Chile, LAC, and MEN all have
decisive support as well, although the rates are lower (0.500, 1.270, 1.620, and 1.398
transitions per year, respectively). Transmission from MEN has strong support to Houston.
Transmissions from LAC and ECA to Houston are very strongly supported. There is decisive
support for transmission from the UC to Houston at a rate of 0.628 transitions per year and to
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Chile at a rate of 1.27 transitions per year, and from Houston to the UC at a rate of 1.58
transitions per year.
Figure 5. Map of Global Transmission Rates for RSV B

Map of global transmission patterns for RSV B. Only transmissions with BF≥3 are shown. The color of the line
indicates the level of support, and the weight of the line indicates the rate of transmission with thicker lines
indicating a higher rate. Arrowheads indicate the direction of transmission. UC is the United States and Canada
region, LAC is Latin America and the Caribbean, ECA is Europe and Central Asia, MEN is the Middle East and
North Africa, AF is Sub-Saharan Africa, and EAP is East Asia and the Pacific.

Markov Jump Counts
The complete history of the Markov jump counts was reconstructed to quantify jump
events in a source-sink model. For global RSV A (Figure 6), the average number of
transmissions between regions (“jump counts”) were highest from ECA to LAC (19.90),
from ECA to the UC (18.62), and from the UC to Chile (17.94). AF, Houston, MEN, SA
were the least common sources of transmissions. ECA was the most common source but not
a major sink for any region. The most common source of transmission to Chile was the UC
region. Chile was the most common source of transmission for ECA at an average of 5.93

28

jumps. ECA and the UC were the most common sources of transmission for Houston, at 9.96
and 7.76 jumps, respectively. Houston was not a common source for any of the geo-regions.
Figure 6. Markov Jump Count Heat Map for RSV A

Darker colors indicate a higher average number of jumps from the source location (origin of transmission) to
the sink location (destination of the transmission). A red star by the average number of jumps indicates that the
transmission route has a BF≥3 meaning that it is supported.

For the global RSV B (Figure 7), we observed that ECA was the most common
source of transmission, with the average number of jumps being highest to the UC (32.63), to
EAP (32.39), and to LAC (18.16). AF, Chile, EAP, LAC, and MEN were rarely the source of
transmissions. The UC was the most common sink. The UC and ECA were the most
common sources of transmission for Chile, with average jump counts of 16.49 and 6.39,
respectively. Chile was not a major source of transmission for any of the geo-regions. The
main sources of transmission into Houston were the same as those for Chile. Houston was a
source of transmission for the UC (8.95), although it was not the major source for UC.
Figure 7. Markov Jump Count Heat Map for RSV B
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Darker colors indicate a higher average number of jumps from the source location (origin of transmission) to
the sink location (destination of the transmission). A red star by the average number of jumps indicates that the
transmission route has a BF≥3 meaning that it is supported.

Clinical Severity Analyses
Clinical Data Description
Clinical data from Chile and Houston was used to explore associations between viral
genetic characteristics and disease severity. After cleaning the data, for RSV A, 60 taxa with
clinical data from Chile and Houston were used. Twenty-three of the sequences were from
Chile and 37 were from Houston. For RSV B severity, 41 taxa were from Chile and Houston.
Thirty-one of the sequences were from Chile and 10 were from Houston. Detailed
distribution and disease severity traits are in Table 1.
Table 1. Number of Cases by Disease Severity Traits for RSV A and RSV B
Disease Severity Traits
Oxygen, Hospitalized, Admitted to ICU
Oxygen, Hospitalized, Not Admitted to ICU
No Oxygen, Hospitalized, Admitted to ICU
No Oxygen, Hospitalized, Not Admitted to ICU
No Oxygen, Not Hospitalized, Not Admitted to
ICU

Number of RSV A
Cases
7
24
2
11
16

Number of RSV B
Cases
4
30
0
4
3

Bayesian Phylogenetic Analysis of Clinical Data
In order to analyze the association between topologies and clinical traits in BaTS to
identify clustering patterns, MCC trees were generated using BEAST. The trees for the RSV
A and RSV B (Figures 8 and 9) clinical data do not exhibit the same ladder shape as the
global trees, but both have bushy leaves, indicating intensive sampling for outbreaks at each
location. Both trees have long branches, which indicates that missing data exist. The clades
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of the RSV A tree are closely tied to the geographic origin, with two clades from Houston
and one clade from Chile. The geographic origins are more interspersed in the RSV B tree,
but there are very few sequences from Houston, where the unrepresented samples may
explain the mixing. The RSV A clade from Chile is dominated by the “oxygen, hospitalized,
not admitted to the ICU” severity traits. While the clades from Houston have a mixture of
severity traits, with the “no oxygen, not hospitalized, not admitted to the ICU” trait making
up the majority of cases. The estimated tMRCA for the clinical RSV A tree was 2007.78
(95% BCI: 2006.54, 2009.05) with a mean substitution rate 1.493x10-3
substitutions/site/year. The Bayesian credible interval is relatively narrow, so the tMRCA
estimate is more certain.
Figure 8. Clinical Maximum Clade Credibility Trees for RSV A

The MCC tree for RSV A from Chile and Houston color coded by severity traits: whether the patient was given
oxygen therapy, whether they were hospitalized, and whether they were admitted to the intensive care unit.

31

Figure 9. Clinical Maximum Clade Credibility Trees for RSV B

The MCC tree for RSV B from Chile and Houston color coded by severity traits: whether the patient was given
oxygen therapy, whether they were hospitalized, and whether they were admitted to the intensive care unit.

For the RSV B clinical data the tMRCA was estimated to be 2001.35 (95% BCI:
1995.01, 2006.41) with a mean substitution rate of 9.562x10-4 substitutions/site/year. Unlike
the RSV A Bayesian credible interval, the RSV B interval is quite wide so there is a large
degree of uncertainty in the tMRCA estimate, which is probably due to missing data. The
vast majority of sequences in the RSV B had the “oxygen, hospitalized, not admitted to the
ICU” trait and they tended to be within the same cluster. The other severity traits were rare
and were interspersed throughout the clades of the tree.
Clustering Analysis of Clinical Severity
Using BaTS, an analysis of the association between disease severity traits and viral
genetic characteristics was conducted. For the RSV A samples, the BaTS analysis yielded a
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significant association between the clinical traits and the phylogeny of the tree when all three
traits were combined (needed oxygen, hospitalized, and admitted to the ICU). The cluster
analysis yielded significant results when oxygen therapy and hospitalization were analyzed
separately. There were no significant associations between clinical traits and the tree
phylogeny for ICU admittance in RSV A. The RSV A AI and PS statistics, which assess all
traits, were significant (Table 2). The significant AI statistic indicates that the traits are
consistent across the internal nodes of the tree, and the significant PS indicates that the
number of trait changes through the ancestral nodes is small. However, not all of the MC
statistics, where each variant of the trait is assessed individually, were significant. The MC
statistic was significant for the “oxygen, hospitalized, not admitted to the ICU” trait and the
“no oxygen, not hospitalized, not admitted to the ICU”, indicating that these traits have larger
monophyletic clades and therefore are associated with the phylogeny of the tree but the other
traits are not.
Table 2. Clustering of Disease Severity Traits for RSV A
RSV A Combined Clinical Traits
Statistic
Observed Mean Significance
AI
3.127
<0.01*
PS
22.392
<0.01*
MC (Oxygen, Hospitalized, No ICU)
5.593
0.02*
MC (Oxygen, Hospitalized, ICU)
1.601
1
MC (No Oxygen, Hospitalized, No ICU)
1.679
0.13
MC (No Oxygen, Not Hospitalized, No ICU)
3.444
0.01*
MC (Oxygen, Hospitalized, ICU)
1
1
Oxygen Therapy
AI
0.983
0.00*
PS
9.318
0.00*
MC (Oxygen)
6.259
0.02*
MC (No Oxygen)
7.464
0.03*
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Hospitalized
AI
PS
MC (Hospitalized)
MC (Not Hospitalized)

1.917
11.784
19.210
3.444

0.01*
0.01*
0.01*
0.03*

Admitted to ICU
AI
1.567
0.32
PS
8.116
0.13
MC (No ICU)
8.985
0.47
MC (ICU)
1.651
0.05
*indicates the null hypothesis can be rejected at a significance level of 0.05.

For RSV B, no significant associations between clinical traits and phylogeny were
found when analyzing all three traits together and each independently (Table 3).
Table 3. Clustering of Disease Severity Traits for RSV B
RSV B Combined Clinical Traits
Statistic
Observed Mean Significance
AI
1.613
0.06
PS
10.722
1
MC (Oxygen, Hospitalized, No ICU)
5.795
0.46
MC (No Oxygen, Hospitalized, No ICU)
1
1
MC (Oxygen, Hospitalized, ICU)
1
1
MC (No Oxygen, Not Hospitalized, No ICU)
1.154
1
Oxygen Therapy
AI
1.038
0.16
PS
6.735
1
MC (Oxygen)
6.473
0.58
MC (No Oxygen)
1.154
1
Hospitalized
AI
1.038
0.18
PS
6.735
1
MC (Hospitalized)
6.473
0.57
MC (Not Hospitalized)
1.154
1
Admitted to ICU
AI
0.819
0.49
PS
4
1
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MC (No ICU)
6.327
0.98
MC (ICU)
1
1
*indicates the null hypothesis can be rejected at a significance level of 0.05

DISCUSSION
Although RSV usually presents with mild, flu-like symptoms, it can cause severe
disease outcomes for infants, especially premature infants, and adults over the age of 65. In
the absence of an FDA-approved vaccine that is widely available, outbreak prevention and
control relies on a firm understanding of transmission patterns and dynamics. Since vaccine
candidates and antiviral treatment are being developed, it is important to identify viral
genetic characteristics that can predict disease severity and be better targets. The aim of this
study was to use RSV full-genome sequence data to gain a better understanding of the global
transmission patterns, the transmission of RSV into and out of Houston and Chile and to
preliminarily test if there are viral characteristics within the F, G, and SH genes associated
with higher severity of disease. To our knowledge, this is the first study to use full genome
data to model and identify RSV global transmission patterns. While other studies have
implied that global transmission dynamics are important for regional and local outbreaks,
very few have tried to elucidate those dynamics, and those studies have relied on solely on
the short sequences of the G gene (Hibino, et al., 2018; Giallonardo, et al., 2018). This is also
the first effort to link characteristics of the three surface proteins to patient outcomes, as
previous studies have focused on RSV genotypes or patient characteristics (Hibino, et al.,
2016; Yoshihara, et al., 2016; Panayiotou, et al., 2014).
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With the estimation from phylogenetic modeling, we estimated that the tMRCA of
RSV A was 1963.40 and the mean substitution rate was 7.43x10-4 substitutions/site/year. Zou
and colleagues reported the tMRCA for the GA2 and GA7 genotypes, which they estimated
to be 1965 (95% HPD: 1970-1975) with a substitution rate of 2.3x10-3 (Zou, et al., 2016).
The phylogenetic tree generated by Zou and colleagues appears to have a similar shape to the
tree we generated for RSV A. The tree shape for RSV A is also similar to the phylogenetic
trees generated in the Elawar, Schobel, and Agoti studies (Elawar, et al., 2017; Schobel, et
al., 2016; Agoti, et al., 2017). The tMRCA from the Zou tree appears to be around 1965,
which is within our 95% BCI (1946.15, 1969.60). The huge differences in the substitution
rates may be due to the differences in the data examined. Zou and colleagues just looked at G
gene data, which is shorter and includes a hypervariable region, while our study looked at all
the currently available full genome data, which may result in a more accurate substitution
rate over the full length of the genome. Agoti and colleagues found a substitution rate of
4.95x10-3 in their study of household transmission dynamics when looking at full genome
data (Agoti, et al., 2017). A study conducted by Giallonardo and colleagues (2018) also
looked at full sequence data, and their estimate of the substitution rate using BEAST was
7.48x10-4 substitutions/site/year for RSV A and 7.39x10-4 substitutions/site/year for RSV B.
Their estimate for RSV A is very similar to the one we have reported here. Since few studies
have focused on RSV B, this study, in addition to the Giallonardo study, provides
preliminary estimates of the evolutionary dynamics of RSV B with tMRCA estimated as
1963.80 and the mean substitution rate as 8.34x10-4 substitutions/site/year.
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The results from the global transmission modeling showed that for both RSV A and
B, ECA was an important source of transmission events for many regions, including Houston
and Chile. Although the rate of transmissions from ECA to UC was high for RSV A, it was
not found to be significant for RSV A. This may be due to the scarce samples from ECA over
years, resulting in insufficient statistical power to detect the significance, though the
transmission rates showed the potential close relationships between these two locations. For
Houston, LAC and MEN were also important sources of RSV A and B transmission. A
potential mechanism for RSV global introductions is air travel, which provides pathogens a
quick way to reach all corners of the globe. RSV is mainly transmitted through fomites and
droplets (Kutter, et al., 2018). Although RSV does not spread as efficiently as an aerosol
(e.g., influenza), transmission could still occur in a small, enclosed space, such as an
airplane. In 2017, 54.2 million people flew into Houston area airports, and of these
passengers, 11.2 million came from international airports (Houston Airport System, 2018).
Houston is the fourth largest city in the United States and is a key business center for the
global oil and gas industry. At Nuevo Paudahuel, the main airport for Santiago, Chile, close
to 50% of the 1.23 million passengers are from international origins (Aeropuerto de Santiago,
2015). The large number of people travelling from around the globe facilitates many
potential RSV introductions.
Studies of influenza have indicated that air travel patterns paired with information on
seasonal peaks of influenza outbreak help explain its global transmission patterns (Kenah, et
al., 2011). A similar phenomenon could be happening with RSV. The peak of RSV in Texas
is usually in December or January, with the number of cases starting to increase in September
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or October (Texas Department of State Health Services, 2018). This peak season overlaps
with peaks in the ECA and MEN regions, which may explain why these transmission routes
are supported (Hendaus, et al., 2018; Sricharoenchai, Palla, & Sanicas, 2016). The peak in
LAC varies since the region includes countries in the northern and southern hemisphere with
both temperate and tropical climates. Within the region, RSV peaks in Mexico would overlap
with the peaks in Houston, but the peaks for Peru, Chile, and Argentina would occur in June,
July, and August (Rodriguez-Auad, et al., 2012; Sricharoenchai, Palla, & Sanicas, 2016),
while the tropical locations in LAC with year-round outbreak may facilitate the seasonality
of both hemispheres. Peaks in Brazil occur over a wide range of time periods that correspond
to the rainy season, with slight overlap with the peaks in Texas (Sricharoenchai, Palla, &
Sanicas, 2016). The peak season overlap does not fully explain transmission from ECA to
Chile since they have opposite peak seasons, but the intermediate links in the tropical areas
may contribute the transmission between LAC and Houston. Further studies are needed to
investigate this connection.
Many studies have taken a genotype-specific approach to RSV phylogeny and focus
on the evolution of each genotype. Zou and colleagues were one of the first to try to
determine the global transmission of RSV A, but they did not investigate transmission routes
(Zou, et al., 2016). Their analysis from genotypes GA2 and GA7 supported the potential of
substantial international movement of RSV lineages although it was not detected in their
current dataset. Our results of RSV global transmission patterns, which focus on the
evolution of all genotypes, support the idea from Zou and Elawar, as well as studies of local
transmissions (Zou, et al., 2016; Elawar, et al., 2017). Therefore, our study with a more
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complete RSV global dataset adds more evidence to the hypothesis that international
transmission events are key to RSV transmission patterns as many routes are statistically
supported in our study.
With the clinical disease severity data from Houston and Chile, we identified a
significant association between the RSV A tree topologies and disease severity. We did not
identify any significant associations in RSV B, which may be due to the small sample size of
the clinical dataset. It is important to note that the clinical RSV dataset only includes the
main circulating genotypes (two RSV A genotypes: GA2 and ON, and one RSV B genotype:
BA), so it may not represent the complete picture of RSV epidemics. Although we did not
analyze the data by genotype, the clusters associated with more severe outcomes are in the
ON clade for RSV A. This association between the ON genotype and increased severity was
also reported in the Hibino and Yoshihara studies, although both of these studies compared
ON to NA1, and not to GA2. Since we had only one genotype of RSV B, we cannot compare
it to the studies that took a genotypic approach.
Our preliminary analysis on disease severity provides some insights on data
collection and future directions. It would be ideal to collect a larger number of samples for
both RSVA and B from patients on both ends of the severity spectrum, those who did not go
to the hospital and those who had to be admitted to the ICU. It would also be better to have
multiple genotypes represented within the sample for easier comparison to previous studies
that related RSV genotype to disease severity. In our analysis, we did not include data on
patient characteristics and other confounding variables that could impact outcome severity
(e.g., patient age or whether they have co-morbidities) or the patients’ viral loads. While this
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preliminary analysis indicates that there are genetic characteristics associated with disease
severity, further analyses should take viral load and patient characteristics into account to
control for these potential confounders. Further studies should also conduct a scan of the
genomes for clades significantly associated with severe outcomes to determine what
variations are associated with more severe outcomes. Identifying critical mutations that lead
to more severe outcomes, and determining how these outcomes are correlated with patient
genetics, can help inform antiviral medication and vaccine development.
This study has some limitations. First, the global data have obvious sampling biases.
The United States and Canada (UC) region are heavily overrepresented in the dataset, while
other regions may only have very scarce samples over countries or over years. For example,
data from Latin American and the Caribbean (LAC) and Sub-Saharan Africa (AF) represent
only one or two countries within that region, data from Europe and Central Asia (ECA)
mainly have samples only for a few years, and South Asia (SA) is not represented at all in the
RSV B dataset. The US in general is heavily overrepresented across both datasets and across
all years, although a large portion of the data from the US comes for a few cohort studies
conducted in localized areas, and so may not be representative of the US as a whole. To
reduce the selection bias in the data, we have subsampled the data by country and year and
conducted sensitivity analysis with multiple subsampled datasets. Another key limitation is
related to using geo-regions to infer transmission dynamics. World Bank regions may be
represented by only one or two countries within that region, so the data may not reflect the
true dynamics of transmission; that is, we cannot determine if the routes are direct, neither
can we determine the intermediate stops within each of those regions. However, inferences
40

drawn from using geo-regions may help us identify key regions where surveillance efforts
need to be increased. Furthermore, some of the disease severity data may not be accurate. For
example, it is unlikely that someone was admitted to the hospital and the ICU for a
respiratory infection but was not given oxygen, but a few of these cases were reported.
Without direct access to patient records, it is impossible to verify the medical treatments
required by each patient. Another limitation of the severity data is the small sample size for
RSV B, which means we are likely underpowered to detect an association between disease
severity and tree topology if an association does exist. Further studies, with more data are
needed to determine if the associations for RSV B are similar to RSV A.
Better surveillance systems to routinely collect global representative samples are
needed in many parts of the world in order to gain an unbiased understanding of global
transmission dynamics. A system proposed by the WHO would help collect more complete
datasets that are more representative of the viral variation around the world (WHO, 2017).
This in turn would lead to more robust inferences on transmission dynamics to determine the
importance of within region persistence and global transmission routes. Further studies of
global transmission dynamics with a more representative dataset could be improved with
more sophisticated population coalescent models. For disease severity, studies need to be
conducted with sequence scans to identify key mutations associated with increased severity.

CONCLUSION
In summary, though data limitations exist, with rigorous subsampling strategy,
phylodynamic modeling and clustering analysis, we were able to depict the global
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transmission patterns of RSV. The ECA region was an important source of RSV A and B
transmission for Chile and Houston, so increased surveillance in this region may help predict
the main genotype of seasonal outbreaks in Chile and Houston, and eventually help guide
vaccine design. Even before a vaccine is available, information about transmission dynamics
can be used to help control the spread of the disease. There was an association between tree
topology and disease severity for RSV A. More data and further studies are needed to
identify which genetic variants are associated with this increased severity.
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APPENDICES
Appendix A: Distribution of Global RSV Samples
Figure A1. Distribution of Sequences by Geo-Region for RSV A(a) and RSV B(b)

The number of RSV A (a) and B (b) sequences from each of the adapted World Bank regions included in the
full dataset.

Appendix B: Transmission Rates for RSV and Level of Support
Table B1. Rates and Level of Support for RSV A Transmission
From
Europe & Central
Asia
East Asia & the
Pacific
Europe & Central
Asia
East Asia & the
Pacific
Latin America & the
Caribbean
Chile
Europe & Central
Asia

To
Latin America & the
Caribbean
United States &
Canada
East Asia & the
Pacific
Middle East & North
Africa

Mean
Rate*

Median
Rate

HPD
lower

HPD
upper

Bayes
Factor

2.666

2.554

1.211

4.362 >100

2.556

2.460

1.061

4.399 >100

2.086

1.983

0.644

3.486 >100

1.678

1.578

0.567

3.036 >100

Chile
Europe & Central
Asia

1.500

1.387

0.345

2.860 >100

1.476

1.395

0.072

2.915

Houston

1.438

1.366

0.427

2.597 >100
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38.003

Europe & Central
Asia
Europe & Central
Asia
Middle East & North
Africa
Middle East & North
Africa
Houston
Chile
East Asia & the
Pacific
Europe & Central
Asia
Middle East & North
Africa
Latin America & the
Caribbean
East Asia & the
Pacific
East Asia & the
Pacific
East Asia & the
Pacific
Sub-Saharan Africa
South Asia
South Asia
South Asia
South Asia

Sub-Saharan Africa
Middle East & North
Africa

1.343

1.276

0.473

2.319 >100

0.972

0.915

0.110

1.878

53.576

Houston
East Asia & the
Pacific
Middle East & North
Africa
East Asia & the
Pacific

0.841

0.746

0.044

1.786

34.560

0.832

0.708

0.051

1.877

71.613

0.787

0.651

0.005

1.896

35.657

0.767

0.679

0.008

1.736

5.120

Chile

0.711

0.623

0.054

1.570

13.105

Chile
Latin America & the
Caribbean

0.666

0.599

0.026

1.473

8.213

0.616

0.510

0.007

1.556

5.250

Houston

0.584

0.485

0.011

1.487

4.499

Houston
Latin America & the
Caribbean

0.515

0.425

0.019

1.252

7.493

0.497

0.420

0.010

1.178

6.512

South Asia
Houston
East Asia & the
Pacific
Latin America & the
Caribbean
Houston
Chile
Europe & Central
Asia

0.468
0.425

0.405
0.338

0.034
0.011

1.063 >100
1.034
75.713

0.345

0.230

0.001

0.945

0.296
0.289
0.269

0.184
0.202
0.201

0.000
0.000
0.000

0.933
23.900
0.858 >100
0.809 >100

0.256

0.187

0.001

0.746

5.626

0.192
0.192

0.116
0.155

0.002
0.001

0.827
0.710

18.069
3.867

0.187

0.174

0.031

0.437 >100

South Asia
Latin America & the
Caribbean
South Asia
Chile
South Asia
Europe & Central
Asia
South Asia
*Ordered by the value of rates.
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10.678

Table B2. Rates and Level of Support for RSV B Transmission
From
Europe & Central
Asia
Europe & Central
Asia
Europe & Central
Asia

To
United States &
Canada
East Asia & the
Pacific
Latin America & the
Caribbean
United States &
Canada
Middle East & North
Africa

Houston
Europe & Central
Asia
United States &
Canada
Chile
Middle East & North
Africa
Houston
Europe & Central
Asia
Houston
East Asia & the
United States &
Pacific
Canada
Europe & Central
Asia
Chile
United States &
Canada
Houston
Latin America & the
Caribbean
Houston
Europe & Central
Asia
Sub-Saharan Africa
United States &
Europe & Central
Canada
Asia
*Ordered by the value of rates.

Mean
Rate*

Median
rate

HPD
lower

HPD
upper

BAYES_FA
CTOR

2.854

2.745

1.272

4.618

>100

2.815

2.723

1.204

4.547

>100

1.620

1.553

0.619

2.685

>100

1.584

1.484

0.343

2.979

>100

1.398

1.323

0.515

2.439

>100

1.270

1.195

0.452

2.262

>100

0.751

0.661

0.017

1.608

23.435

0.652

0.586

0.045

1.353

89.947

0.642

0.538

0.000

1.618

3.947

0.632

0.592

0.092

1.260

>100

0.628

0.562

0.107

1.324

>100

0.571

0.491

0.029

1.321

41.055

0.500

0.452

0.072

1.023

>100

0.454

0.408

0.050

0.950

21.471
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